Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    June 2018
  1. QI LN, Xiang BD, Wu FX, Ye JZ, et al
    Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
    Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
    PubMed     Text format     Abstract available



  2. Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3400.
    PubMed     Text format    



  3. Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3399.
    PubMed     Text format    


  4. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Text format     Abstract available


    May 2018
  5. MENG J, Chen S, Han J, Qian B, et al
    Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
    PubMed     Text format     Abstract available


  6. WEN LZ, Ding K, Wang ZR, Ding CH, et al
    SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
    PubMed     Text format     Abstract available


    March 2018
  7. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Text format     Abstract available


    February 2018
  8. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Text format     Abstract available


  9. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Text format     Abstract available


  10. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Text format     Abstract available


    January 2018
  11. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Text format     Abstract available


    December 2017
  12. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Text format     Abstract available


    November 2017
  13. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Text format     Abstract available


  14. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Text format     Abstract available


    October 2017
  15. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Text format     Abstract available


  16. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Text format     Abstract available


    September 2017
  17. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available


  18. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Text format     Abstract available


  19. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available


    August 2017
  20. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Text format     Abstract available


  21. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Text format     Abstract available


  22. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Text format     Abstract available


    July 2017
  23. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Text format     Abstract available


  24. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Text format     Abstract available


  25. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Text format     Abstract available


    June 2017
  26. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Text format     Abstract available


  27. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Text format     Abstract available


    April 2017
  28. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available


  29. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available


  30. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available


    March 2017
  31. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available


    February 2017
  32. LIN DC, Mayakonda A, Dinh HQ, Huang P, et al
    Genomic and epigenomic heterogeneity of hepatocellular carcinoma.
    Cancer Res. 2017 Feb 20. pii: canres.2822.2016.
    PubMed     Text format     Abstract available


  33. YAN C, Yang Q, Gong Z
    Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish.
    Cancer Res. 2017 Feb 15. pii: canres.2200.2016.
    PubMed     Text format     Abstract available


    January 2017
  34. LUO C, Cheng Y, Liu Y, Chen L, et al
    SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development.
    Cancer Res. 2017 Jan 12. pii: canres.1919.2016.
    PubMed     Text format     Abstract available


    December 2016
  35. MALAKAR P, Shilo A, Mogilavsky A, Stein I, et al
    Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation.
    Cancer Res. 2016 Dec 19. pii: canres.1508.2016.
    PubMed     Text format     Abstract available


    November 2016
  36. CHEN G, Nakamura I, Dhanasekaran R, Iguchi E, et al
    Transcriptional induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD signaling axis mediates tumor angiogenesis in hepatocellular carcinoma.
    Cancer Res. 2016 Nov 21. pii: canres.2556.2015.
    PubMed     Text format     Abstract available


    October 2016
  37. MAO X, Wong SY, Tse EY, Ko FC, et al
    Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2016 Oct 26. pii: canres.1031.2016.
    PubMed     Text format     Abstract available


    September 2016
  38. TANG B, Qi G, Tang F, Yuan S, et al
    Aberrant JMJD3 expression upregulates Slug to promote migration, invasion and stem cell-like behaviors in hepatocellular carcinoma.
    Cancer Res. 2016 Sep 20. pii: canres.3029.2015.
    PubMed     Text format     Abstract available


  39. ALLAIN C, Angenard G, Clement B, Coulouarn C, et al
    Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma.
    Cancer Res. 2016 Sep 12. pii: canres.1559.2016.
    PubMed     Text format     Abstract available


  40. ZHANG L, Ge C, Zhao F, Zhang Y, et al
    NRBP2 overexpression increases the chemosensitivity of hepatocellular carcinoma cells via Akt signaling.
    Cancer Res. 2016 Sep 7. pii: canres.0937.2016.
    PubMed     Text format     Abstract available


    August 2016
  41. WOLF B, Krieg K, Falk C, Breuhahn K, et al
    Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma.
    Cancer Res. 2016 Aug 3. pii: canres.3453.2015.
    PubMed     Text format     Abstract available


    June 2016
  42. LI K, Shen B, Cheng X, Ma D, et al
    Phenotypic and signaling consequences of a novel aberrantly spliced transcript FGF receptor-3 in hepatocellular carcinoma.
    Cancer Res. 2016 Jun 7. pii: canres.3385.2015.
    PubMed     Text format     Abstract available


    May 2016
  43. RIZZA S, Montagna C, Cardaci S, Maiani E, et al
    <i>S</i>-nitrosylation of the mitochondrial chaperone TRAP1 sensitizes hepatocellular carcinoma cells to inhibitors of succinate dehydrogenase.
    Cancer Res. 2016 May 23. pii: canres.2637.2015.
    PubMed     Text format     Abstract available


    April 2016
  44. HIRATA H, Sugimachi K, Komatsu H, Ueda M, et al
    Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Cancer Res. 2016 Apr 6. pii: canres.2601.2015.
    PubMed     Text format     Abstract available


    March 2016
  45. LIN D, Lei L, Liu Y, Zhang Y, et al
    Membrane IL1alpha Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  46. LU Y, Li N, Gao L, Xu YJ, et al
    Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma.
    Cancer Res. 2016 Mar 14. pii: canres.3199.2015.
    PubMed     Text format     Abstract available


  47. LIU L, Zhao X, Zhao L, Li J, et al
    Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.
    Cancer Res. 2016;76:1260-72.
    PubMed     Text format     Abstract available


    February 2016
  48. MARKOWITZ GJ, Yang P, Fu J, Michelotti GA, et al
    Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes.
    Cancer Res. 2016 Feb 18. pii: canres.1548.2015.
    PubMed     Text format     Abstract available


  49. YE LY, Chen W, Bai XL, Xu XY, et al
    Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  50. BORGHESAN M, Fusilli C, Rappa F, Panebianco C, et al
    DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  51. TANEI T, Leonard F, Liu X, Alexander JF, et al
    Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
    Cancer Res. 2016;76:429-39.
    PubMed     Text format     Abstract available


    December 2015
  52. CHEN HN, Yuan K, Xie N, Wang K, et al
    PDLIM1 stabilizes the E-cadherin/beta-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells.
    Cancer Res. 2015 Dec 23. pii: canres.1962.2015.
    PubMed     Text format     Abstract available


    April 2015
  53. BONASTRE E, Verdura S, Zondervan I, Facchinetti F, et al
    PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.
    Cancer Res. 2015;75:1287-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: